ARA-290- 16mg - Animal Research Peptide

Description

Form: Lyophilized Powder
Quantity: 16mg per vial
Purity: ≥ 99% (HPLC Verified)

Product Overview:

Ara-290 (cibinetide) is an 11–amino acid non-erythropoietic peptide derived from erythropoietin’s helix-B domain. It selectively activates the innate repair receptor (IRR), an EPOR/CD131 heterodimer, to promote anti-inflammatory and tissue-protective effects without stimulating red blood cell production. Clinical trials have demonstrated benefits for diabetic neuropathy and sarcoidosis-related small-fiber neuropathy

Applications in Research:

• Investigations into incretin biology and insulin regulation

• Preclinical models of obesity and glucose metabolism

• Studies on energy balance, appetite signaling, and lipid metabolism

• Research into gut-brain axis and metabolic inflammation

Dosing Protocol

Suggested daily titration approach reflecting clinical study parameters.

• Start: 2 mg daily during week 1 to assess tolerance.
• Target: 4 mg daily from week 2 onward^[3].
• Frequency: Once per day (subcutaneous).
• Cycle Length: 4–8 weeks standard; may extend to 16 weeks based on individual assessment.
• Timing: Any consistent time daily; rotate injection sites.

Storage & Handling:

Store lyophilized Tirzepatide at -20°C in a light- and moisture-protected environment.
Reconstitute with sterile bacteriostatic water under sterile conditions. Store reconstituted solution at 2–8°C and use according to laboratory protocol. Avoid multiple freeze-thaw cycles.

⚠️ Research Use Only – Legal Disclaimer

All products on this site are for research and development use only. Products are not for human consumption of any kind. The statements made on this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure, or prevent any disease.

Biogenic Foods, LLC is a chemical supplier. Biogenic Foods is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic Act. Biogenic Foods is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic Act.

All products are sold for research, laboratory, or analytical purposes only, and are not for human consumption.